DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 30 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $117,171 | +166.3% | 27,123 | -23.1% | 0.00% | – |
Q3 2022 | $44,000 | -72.8% | 35,258 | -56.0% | 0.00% | – |
Q2 2022 | $162,000 | +3.2% | 80,200 | +27.7% | 0.00% | – |
Q1 2022 | $157,000 | -50.0% | 62,824 | -25.7% | 0.00% | – |
Q4 2021 | $314,000 | -23.8% | 84,530 | -17.8% | 0.00% | – |
Q3 2021 | $412,000 | -1.9% | 102,829 | +9.0% | 0.00% | – |
Q2 2021 | $420,000 | – | 94,365 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 419,942 | $1,869,000 | 0.98% |
Manatuck Hill Partners, LLC | 570,500 | $2,539,000 | 0.77% |
Corriente Advisors, LLC | 203,641 | $906,000 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 275,000 | $1,224,000 | 0.40% |
Ikarian Capital, LLC | 415,000 | $1,847,000 | 0.15% |
COOPERMAN LEON G | 50,000 | $223,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 46,562 | $207,000 | 0.01% |
Trexquant Investment LP | 17,019 | $76,000 | 0.01% |
TWO SIGMA SECURITIES, LLC | 30,511 | $136,000 | 0.00% |
MARSHALL WACE, LLP | 155,662 | $693,000 | 0.00% |